Linical Accelovance

Linical Accelovance was a global contract research organization focused on providing full-service clinical development support to pharmaceutical, biotechnology, CRO, and academic clients. The company managed Phase I-IV clinical trials and offered services such as project management, monitoring, biostatistics, data management, pharmacovigilance, regulatory affairs, medical writing, and patient engagement solutions. Therapeutic strengths highlighted across company materials included oncology, hematology, vaccines, neurology, dermatology, pain, nutrition, and women's health. Accelovance was acquired by Japan-based Linical in April 2018, after which the combined organization increasingly operated under the Linical and later Linical Americas branding rather than as an independent standalone company.